The Impact of Stereoisomerism in Bioequivalence Studies
Authors:
- Gordon McKayGMGordon McKay
- Maureen J. RawsonMRMaureen J. Rawson
- John W. HubbardJHJohn W. Hubbard
- 1 July 1998
- journal article
- review article
- Published by American Geophysical Union (AGU) in Journal of Pharmaceutical Sciences
- Vol. 87 (7) , 797-802
Abstract
Journal of Pharmaceutical Sciences, pharmacokinetics, biopharmaceutics, pharmacodynamics, drug development, protein-peptide chemistry, drug deliveryKeywords
This publication has 48 references indexed in Scilit:
- Chirality in New Drug DevelopmentClinical Pharmacokinetics, 1994
- Stereoselective and isozyme‐selective drug interactionsChirality, 1993
- The Importance of Stereochemistry in Drug Action and DispositionThe Journal of Clinical Pharmacology, 1992
- Enantioselective pharmacodynamics and pharmacokinetics of chiral non-steroidal anti-inflammatory drugsEuropean Journal of Clinical Pharmacology, 1992
- Stereoselectivity in clinical pharmacokinetics and drug developmentEuropean Journal of Drug Metabolism and Pharmacokinetics, 1990
- Enantiomer specific pharmacokineticsPharmacology & Therapeutics, 1990
- Enantioselective Aspects of Drug Action and Disposition: Therapeutic PitfallsJournal of Pharmaceutical Sciences, 1989
- Stereoselective drug disposition: potential for misinterpretation of drug disposition data.British Journal of Clinical Pharmacology, 1988
- Bias in pharmacokinetics and clinical pharmacologyClinical Pharmacology & Therapeutics, 1987
- Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacologyEuropean Journal of Clinical Pharmacology, 1984